Nippon Sanso : Q3 FYE2025 Consolidated Financial Results Earnings Announcement

About this update from Nippon Sanso Holdings Corporation

Q3 FYE2025 Consolidated Financial Results Earnings Announcement ( Nine months ended December, 2024 ) February 5, 2025 Tokyo, Japan Notes Analysis of Operating Results (Reasons for change in Revenue and Segment Operating Income) In the supplementary materials to the financial statements of NSHD, starting from the fiscal year ending March 31, 2022, NSHD will describe the status of the business results of NSHD group on a quarterly consolidated accounting period basis, as well as its recognition and analysis of the status of the business results of NSHD group from management's perspective. Please note that Segment Operating Income is based on Core Operating Income. The following table shows Revenue, Operating income, and the effect of Forex rate changes on Revenue and Operating Income. The impact of Forex rate fluctuation is calculated by applying the average rate for the period under review to the period under review (the current period and the previous period). These disclosures are not in accordance with International Financial Reporting Standards (IFRS). However, we believe that these disclosures are useful analytical information for investors to understand the business conditions of the Group. ＜ Forex rates ＞ Average Forex rates FYE2024 FYE2025 FYE2025 FYE2025 (Updated) (Previous) Full-term Full-term Unit ： JPY Q1 1st Half 9M Full-term Q1 1st Half 9M Full-term Assumption Assumption Currency （ Apr.-Jun. ） （ Apr.-Sep. ） （ Apr.-Dec. ） （ Apr.-Mar. ） （ Apr.-Jun. ） （ Apr.-Sep. ） （ Apr.-Dec. ） （ Apr.-Mar. ） （ Apr.-Mar. ） （ Apr.-Mar. ） (Announced on Feb 5, 2025) (Announced on May 13, 2024) USD 139.63 142.61 143.78 145.31 158.24 152.45 153.03 152.89 145.31 EUR 151.89 154.81 156.24 157.72 170.08 165.83 165.09 165.28 157.72 SGD 103.66 105.79 106.90 108.03 116.65 114.37 114.58 114.37 108.03 AUD 91.94 93.44 94.47 95.32 104.66 101.80 100.91 101.80 95.32 CNY 19.67 19.87 20.01 20.20 21.76 21.20 21.25 21.20 20.20 （ Reference ） Currency sensitivity as rough indication Impact of devaluation by 1 JPY Unit ： ¥ bn. (Full-term basis) Currency Revenue Core Operating Income USD +2.4 +0.35 EUR +1.9 +0.35 3 Presentation of overall business performance and segment performance The amounts shown are after offsetting and elimination of inter-segment transactions and do not include consumption tax etc. Notes that from Q3 FYE2023, the reportable segment names simplified, but the scope of segment aggregation didn't change. February 5, 2025 | NIPPON SANSO Holdings Supplementary Materials FYE2025 Q3 results Contents Strategic overview Q3 FYE2025 Business performance -1. Q3 performance (Oct. - Dec.) -2. Nine months performance 3. FYE2025 Full-term Forecast Appendix 4 February 5, 2025 | NIPPON SANSO Holdings Supplementary Materials FYE2025 Q3 results 1. Strategic overview 5 February 5, 2025 | NIPPON SANSO Holdings Supplementary Materials FYE2025 Q3 results 1. Strategic overview Our Perspective Respond flexibly to different circumstances/risks/opportunities of each business Pursue a higher level of business structure in each region NS Holdings provides strong support, while enabling local operation of each region e.g. Strengthening engineering capabilities and healthcare sector (Europe) Expanding industrial gas business (Australia) 6 February 5, 2025 | NIPPON SANSO Holdings Supplementary Materials FYE2025 Q3 results 1. Strategic overview NS Vision 2026 | Enabling the Future Our Medium-term Management plan (MTP) Group Philosophy Proactive. Innovative. Collaborative. Making life better through gas technology. The Gas Professionals Group Vision We aim to create social value through innovative gas solutions that increase industrial productivity, enhance human well-being and contribute to a more sustainable future. 7 February 5, 2025 | NIPPON SANSO Holdings Supplementary Materials FYE2025 Q3 results 1. Strategic overview NS Vision 2026 | Enabling the Future Our Medium-term Management plan (MTP) 8 February 5, 2025 | NIPPON SANSO Holdings Supplementary Materials FYE2025 Q3 results 1. Strategic overview Acquisition of industrial gas business in Oceania :Significantly expanding our presence Signed an agreement to acquire *1 100% shares of Coregas Group *2 , which operates industrial gas businesses in Australia and New Zealand. Expanding the footprint of the business enables a notable increase in industrial gas market presence. We will create new growth opportunities and synergies by leveraging Coregas Group's complementary business and product ranges to our existing business. Business Features Main Products Existing business *3 LPG business is primary Industrial gas business LPG CO2, Dry Ice Industrial Gas (Package) Acquired *1 business Industrial Gas business mainly Package, also supplies Bulk, On-site New Zealand: mainly Package Air Separate Gas (Oxygen, Nitrogen, Argon) ASU (Air Separation Unit) Other Features Small x 3 Medical homecare Hydrogen plant (Small) etc. Large x 1, Small x 1 + Small x 1 (under construction) Medical Gas bulk supply Hydrogen plant (Medium) Specialty Gases facility etc. Existing business locations of Supagas *3 Business locations of Coregas Group to be acquired *1 *1 Subjected to approval by the Foreign Investment Review Board (FIRB) and the Australian Competition and Consumer Commission (ACCC). *2 Three business entities which are currently subsidiaries of Wesfarmers Limited: Coregas Pty Ltd, Blacksmith Jacks Pty Ltd and Coregas NZ Limited *3 Includes the LPG sales business in northern/western Australia acquired from Wesfarmers Chemicals, Energy and Fertilisers. 9 February 5, 2025 | NIPPON SANSO Holdings Supplementary Materials FYE2025 Q3 results 1. Strategic overview Acquisition of Homecare business in Spain :Strengthening resilience Nippon Gases, European business company, signed an agreement to acquire *1 100% of Esteve Teijin Healthcare (ETH), which operates a homecare business in Spain, including homecare and respiratory services. Nippon Gases strengthens its position by capturing growing resilient market of homecare business. The team will provide higher quality services through sharing know-how and operational collaboration with its existing homecare business *2 in Spain. Esteve Teijin Healthcare, S.L. Esteve Teijin Healthcare (ETH), a joint venture 50/50 between Teijin and Corporación Químico Farmacéutica Esteve, is an expert and benchmark company in home respiratory therapies. ETH has more than 30 Care Centers, multiple consultations integrated into Health Centers and 8 logistics centers with 300 employees, care for more than 150,000 homecare patients in Spain. ETH aims improving health and well-being results by promoting adherence to treatment and providing high quality standards. ETH is geographically complementary with Nippon Gases Group. Nippon Gases *2 ETH *1 Subjected to approval by the Spanish National Competition Commission (Comisión Nacional de los Mercados y de la Competencia) *2 Homecare business in Spain is operated by Oximesa S.L.U., a subsidiary of Nippon Gases 10 February 5, 2025 | NIPPON SANSO Holdings Supplementary Materials FYE2025 Q3 results Attention : This is an excerpt of the original content. To continue reading it, access the original document here .

View stock analysis, news, and events for Nippon Sanso Holdings Corporation